SOBI
SWTOYDrugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Avatrombopag
Chemotherapy-induced Thrombocytopenia
Avatrombopag Oral Tablet
Immune Thrombocytopenia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Avatrombopag | Phase 3 | Chemotherapy-induced Thrombocytopenia | - | - |
Avatrombopag Oral Tablet | Phase 3 | Immune Thrombocytopenia | - | - |
Frequently asked questions
What is in SOBI's drug pipeline?→
CatalystAlert tracks 2 drug candidates in SOBI's (SWTOY) pipeline across Phase 3. Its lead program is Avatrombopag (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SOBI's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for SOBI (SWTOY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SWTOY biotech catalysts?→
Add SWTOY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SOBI's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.